Valuation: Safe Fertility Group

Market Cap 1.73B 52.08M 45.56M 42.02M 38.81M 73.64M 4.97B 74.88M 502M 197M 2.45B 196M 191M 8.41B P/E 2026 *
11.6x
P/E 2027 * 11.1x
Enterprise Value 1.73B 52.08M 45.56M 42.02M 38.81M 73.64M 4.97B 74.88M 502M 197M 2.45B 196M 191M 8.41B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.14x
Free-Float
23.1%
Yield 2026 *
7.54%
Yield 2027 * 7.72%
05-08 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-20 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-18 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
06/08/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
07/05/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
29/04/25 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
19/02/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
19/02/25 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
06/11/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
01/11/24 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
06/08/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
01/05/24 41,792,822 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-MAY-2024. CI
1 day+0.88%
1 week-0.87%
1 month+1.79%
3 months-5.00%
6 months-3.39%
Current year-10.24%
1 week 5.5
Extreme 5.5
5.85
1 month 5.5
Extreme 5.5
5.85
Current year 5.5
Extreme 5.5
6.9
1 year 5.5
Extreme 5.5
7.95
3 years 5.5
Extreme 5.5
23.7
5 years 5.5
Extreme 5.5
23.7
10 years 5.5
Extreme 5.5
23.7
Manager TitleAgeSince
Chief Executive Officer 60 31/12/2006
Director of Finance/CFO 45 -
Chief Operating Officer 59 19/07/2009
Director TitleAgeSince
Director/Board Member 59 17/11/2019
Chairman 67 17/11/2019
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
01-19Buy

Chief Executive Officer

10,000 0.0033%
01-18Buy

Chief Executive Officer

62,000 0.0204%
01-11Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%-0.87%-19.72% - 52.08M
+1.30%-0.54%+60.77%+46.13% 133B
-0.59%-0.95%+8.12%+37.97% 90.2B
+0.83%+0.33%+1.50%+69.94% 27.41B
-0.29%-3.84%+23.41%+47.87% 22.96B
-1.75%-0.28%-19.43%-28.11% 19.9B
-1.22%+0.26%+16.22%+147.88% 17.59B
+2.48%+0.76%+8.17%+14.97% 15.5B
+1.45%-0.90%+63.31%+125.87% 14.95B
+0.22%+2.02%-9.36%-4.92% 12.75B
Average +0.33%-0.49%+13.30%+50.84% 35.42B
Weighted average by Cap. +0.40%-0.60%+28.90%+47.06%

Financials

2026 *2027 *
Net sales 744M 22.37M 19.56M 18.04M 16.67M 31.62M 2.13B 32.16M 216M 84.67M 1.05B 83.98M 82.15M 3.61B 808M 24.3M 21.26M 19.61M 18.11M 34.37M 2.32B 34.94M 234M 92.01M 1.14B 91.26M 89.27M 3.93B
Net income 148M 4.45M 3.89M 3.59M 3.32M 6.29M 424M 6.4M 42.89M 16.84M 209M 16.71M 16.34M 719M 156M 4.7M 4.12M 3.8M 3.51M 6.65M 449M 6.76M 45.35M 17.81M 221M 17.66M 17.28M 760M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services categories include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
10/07/26 THB 5.700 +0.88% 41,910
09/07/26 THB 5.650 0.00% 435,030
08/07/26 THB 5.650 -2.59% 446,200
07/07/26 THB 5.800 0.00% 83,710
06/07/26 THB 5.800 +0.87% 118,116
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.700THB
Average target price
8.475THB
Spread / Average Target
+48.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock